This study is in progress, not accepting new patients
A Study of FOR46 in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Sandy Wong
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Sandy Wong
Assistant Professor, Medicine, School of Medicine. Authored (or co-authored) 83 research publications. Research interests: amyloidosis · plasma cell dyscrasias · multiple myeloma · MGUS · SMM
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Fortis Therapeutics, Inc.
- ID
- NCT03650491
- Phase
- Phase 1 Multiple Myeloma Research Study
- Study Type
- Interventional
- Participants
- At least 31 people participating
- Last Updated